Enlivex Therapeutics Ltd. (ENLV)
NASDAQ: ENLV · Real-Time Price · USD
1.240
+0.060 (5.08%)
At close: Dec 20, 2024, 4:00 PM
1.270
+0.030 (2.42%)
After-hours: Dec 20, 2024, 6:40 PM EST
Enlivex Therapeutics Market Cap
Enlivex Therapeutics has a market cap or net worth of $27.27 million as of December 20, 2024. Its market cap has decreased by -14.25% in one year.
Market Cap
27.27M
Enterprise Value
3.53M
1-Year Change
-14.25%
Ranking
Category
Stock Price
$1.24
Market Cap Chart
Since July 31, 2014, Enlivex Therapeutics's market cap has decreased from $92.70M to $27.27M, a decrease of -70.59%. That is a compound annual growth rate of -11.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 25.90M | -48.41% |
| Dec 29, 2023 | 50.20M | -30.76% |
| Dec 30, 2022 | 72.50M | -36.74% |
| Dec 31, 2021 | 114.60M | 31.57% |
| Dec 31, 2020 | 87.10M | 2,388.57% |
| Dec 31, 2019 | 3.50M | 34.62% |
| Dec 31, 2018 | 2.60M | -65.33% |
| Dec 29, 2017 | 7.50M | -49.32% |
| Dec 30, 2016 | 14.80M | -73.14% |
| Dec 31, 2015 | 55.10M | -33.69% |
| Dec 31, 2014 | 83.10M | -10.36% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Forte Biosciences | 28.27M |
| Allurion Technologies | 27.45M |
| KALA BIO | 27.29M |
| IRIDEX | 27.28M |
| DarioHealth | 27.28M |
| NextCure | 27.17M |
| LAVA Therapeutics | 27.09M |
| Pluri | 26.79M |